Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice

Blood

Volumn 90, Issue 12, 1997, Pages 4910-4917

  Iversen, Per O ^b   Lewis, Ian D ^b   Turczynowicz, Suzanne ^b   Hasle, Henrik ^b   Niemeyer, Charlotte ^b   Schmiegelow, Kjeld ^b   Bastiras, Stan ^b   Biondi, Andrea ^b   Hughes, Timothy P ^b   Lopez, Angel F ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY CA 2; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; CANCER TRANSPLANTATION; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL; MALE; MOUSE; MYELOMONOCYTIC LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

EID: 0031470405     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.12.4910.4910_4910_4917     Document Type: Article

References (34)

1. Castro-Malaspina H, Schaison G, Passe S, Pasquier A, Berger R, Bayle-Weisgerber C, Miller D, Seligmann M, Bernard J: Subacute and Chronic myelomonocytic leukemia in children (juvenile CML). Cancer 54:675, 1984
2. Hasle H, Kerndrup G, Jacobsen BB: Childhood myelodysplastic syndrome in Denmark: Incidence and predisposing conditions. Leukemia 9:1569, 1995
3. Chan HSL, Estrov Z, Weitzman SS, Freedman MH: The value of intensive combination chemotherapy for juvenile chronic myelogeneous leukemia. J Clin Oncol 5:1960, 1987
4. Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N, Jacobsen BB: Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 10:1269, 1996
5. Sanders JE, Buckner CD, Thomas ED, Fleisher R, Sullivan KM, Appelbaum FA, Storb R: Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 71:1144, 1988
6. Katz F, Hann I, Kinsey S, Ball S, Morgan G, Chessells J: Assessment of graft status following allogenic bone marrow transplantation for haematological disorders in children using locus-specific minisatellite probes. Br J Haematol 83:473, 1993
7. Freedman MH, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z: Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogeneous leukaemia. Br J Haematol 80:40, 1992
8. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS: Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77:925, 1991
9. Gualtieri RJ, Emanuel PD, Zuckerman KS, Martin G, Clark SC, Shadduck RK, Dracker RA, Akabutu J, Nitschke R, Hetherington ML, Dickerman JD, Hakami N, Castleberry RP: Granulocyte-macrophage colony-stimulating factor is an endogeneous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood 74:2360, 1989
10. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nf1 deficiency causes ras-mediated granulocyte-macrophage colony-stimulating factor hypersensitivity and chronic leukaemia. Nat Genet 12:137, 1996
11. Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K: Loss of NF1 results in activation of the ras signaling pathway and leads to abberant growth in haematopoietic cells. Nat Genet 12:144, 1996
12. Emanuel PD, Bates LJ, Zhu S-W, Castleberry RP, Gualtieri RJ, Zuckerman KS: The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Exp Hematol 19:1017, 1991
13. Iversen PO, Rodwell RL, Pitcher L, Taylor KM, Lopez AF: Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. Blood 88:2634, 1996
14. Lang RA, Metcalf D, Cuthberson RA, Lyons I, Stanley E, Kelso A, Kannourakis G, Williamson DJ, Klintworth GK, Gonda TJ, Dunn AR: Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51:675, 1987
15. Hercus, TR, Bagley CJ, Cambareri B, Dottore M, Woodcock JM, Vadas MA, Shannon MF, Lopez AF: Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc Natl Acad Sci USA 91:5838, 1994
16. Kochetkova M, Iversen PO, Lopez AF, Shannon MF: Deoxyribonucleic acid triplex formation inhibits granulocyte-macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells. J Clin Invest 99:3000, 1997
17. Siegel SA, Nakada MT, Le J, Woulfe DS, Probert L, Kollias G, Ghrayeb J, Vilcek J, Daddon PE: The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Cytokine 7:15, 1995
18. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105, 1994
19. Uckun FM: Severe combined immunodeficient mouse models of human leukemia. Blood 88:1135, 1996
20. Lapidot T, Grunberger T, Vormoor J, Estrov Z, Kollet O, Bunin N, Zaizov R, Williams DE, Freedman MH: Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice. Blood 88:2655, 1996
21. Knight DM, Thrinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, Ghrayeb J: Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 30:1443. 1993
22. Kamel-Reid S, Dick JE: Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706, 1988
23. Lichter P,Tang CC, Call K, Hermanson G, Evans GA, Houseman D, Ward D: High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64, 1990
24. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE: Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87:1539, 1996
25. Freeburn RW, Gale RE, Wagner HM, Linch DC: Analysis of the coding sequence for the GM-CSF receptor α and β chains in patients with juvenile chronic myeloid leukemia (JCML). Exp Hematol 25:306, 1997
26. Miyauchi J, Atsada M, Sasuki M, Tsunematsu Y. Kojima S, Mizutani S: Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248, 1994
27. ras. Blood 84:3435, 1994
28. Satoh T, Nakafuku M, Miyajima A, Kaziro Y: Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 88:3314, 1991
29. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Birdsall-Maller I, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180, 1995
30. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645, 1994
31. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE: A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 246:1597, 1989
32. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379:645, 1996
33. Iversen PO, To LB, Lopez AF: Apoptosis of hemopoietic cells by the human granulocyte-macrophage colony-stimulating factor mutant E21R. Proc Natl Acad Sci USA 93:2785, 1996
34. Iversen PO, Mortensen BT, Nicolaysen G, Benestad HB: Decreased blood flow to rat bone marrow, bone, spleen, and liver in acute leukemia. Leuk Res 17:663, 1993